Exam 2: Pulmonary TB Flashcards

1
Q

Pulmonary Tuberculosis

A

Infectious disease cause by mycobacterium tuberculosis.

Usually involves lungs but can infect any part of the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Factors of resurgence of TB

A

High rates of TB among HIV patients

Emergency of MDR strain of M. Tuberculosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the leading cause of death from infection in the world?

A

TB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Risk Factors for TB

A
  • Contact with person w/ active TB
  • Immuno-compromised Status/Preexisting Medical Condition
  • Inadequate Health Care (d/t lack of screen and health promotion)
  • Immigration
  • Institution
  • Substance Abuse
  • Substandard Housing
  • High risk jobs
  • Overcrowding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Why are patients taking prednisone at an increased risk for TB?

A

Prednisone treats inflammation -> lowers resistance -> lowers WBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why do patients who have had transplants at an increased risk for TB?

A

D/t lifelong immunosuppressant therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

TB occurs commonly in

A

Poverty
Minorities
Undeserved

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Types of TB Drug Resistance

A

Primary Drug Resistance
Secondary Drug Resistance
Multiple Drug Resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Drug resistance results from

A

Incorrect prescribing
Lack of PH care management
Patient non-adherence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How is TB spread?

A

Via airborne droplets. Can also be spread vi lymph and blood.
Can be suspended in the air for minutes to hours.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Factors influencing the likelihood of transmission

A

of organisms expelled in air
Concentration of organisms
Length of exposure
Immune system of exposed person

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Pathophysiology of TB

A
  1. Patient inhales m. Tuberculosis bacilli
  2. Infection of the tracheobroncheal tree
  3. Multiply in the alveoli
  4. Transport to other body parts via lymph/blood
  5. Inflammatory Process
  6. Neutrophils/macrophage engulf bacteria
  7. Accumulation of exudate in the lung/lobe
  8. Granulomas formation
  9. Transformation to a fibrous mass (Ghon tuberculi)
  10. Formation of a cheesy mass and cavitation of lobe tissue necrosis
  11. Calcification and form collagen scar
  12. Bacteria becomes dormant/no progression of the disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ghon Focus

A

Neutrophil and macrophage try to contain local bacteria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Granuloma

A

Defense mechanism -> walls off infection and prevents further spreading.
Secondary to exudate accumulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ghon tuberculi

A

Starts to harden and adds weight to it
Circulation obliterated by weighing down on capillary blood vessels in lung
Oxygen deprived in tissue in lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Primary infection

A

Bacteria is inhaled and initiates inflammatory reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Latent TB Infection

A

Occurs in person who does not have active TB.
Cannot transmit to others
Treatment is important d/t being able to develop active disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Active TB Disease

A

immune response not adequate and bacteria replicates

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Primary TB: develops w/i

A

first 2 years of infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Postprimary TB or “reactivation”: disease occurring

A

2+ years after initial infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Latent TB Infection: Clinical Manifestations

A

Positive skin test but is asymptomatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Pulmonary TB: Clinical Manifestations

A
Develops 2-3 weeks after infection/reactivation
Initial dry cough → productive cough w. mucopurulent sputum
Fatigue*
Unexplained weight loss*
Low grade fever*
Night sweats*
Dyspnea (late symp.)
Hemoptysis (late symp.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Acute Symptoms of TB

A
Generalized flu symp. 
High fever
Chills
Pleuritic pain
Productive cough
24
Q

TB findings upon auscultation

A

Normal

Or reveal crackles, ronchi, bronchial breath sounds

25
Q

Extra pulmonary TB

A

Depends on organs it affects

E.g. renal TB → dysuria and hematuria

26
Q

Appropriately treated TB

A

Heals w/o complications

Scar and residual cavitation w/i lung

27
Q

Military TB

A

Widespread of bacteria via bloodstream to distant organs

Fatal if left untreated

28
Q

Pleural TB

A

From primary disease or reactivation
Pleural effusion d/t bacteria in pleural space
Causes inflammatory response → exudate of protein rich fluid

29
Q

Acute TB Complications

A

d/t large amounts of tubercle bacilli discharged from granulomas into lung/lymph

30
Q

TB: Diagnostic Studies

A

TB Skin Test
AFB Smear
CXR
Sputum Culture/Sensitivity

31
Q

TB Skin Test

A

..

32
Q

CXR

A

Can’t make dx off CXR

Upper lobe filtrates, cavitary infiltrates, lymph node involvement

33
Q

Sputum Culture

A

Dx of TB requires demonstration by tb bacilli

Stained sputum smears for AFB: 3 consecutive samples must be collected on different days

34
Q

Management of TB

A
  • treated primarily with chemo therapeutic agent for 6-12 mons (short / term chemo therapy)
  • use of multiple drug therapy
35
Q

Patients with a positive TB sputum smear are considered

A

Infectious for first 2 weeks after starting treatment.

36
Q

Drug Therapy: Main Treatment for TB

A

Two phases: initial and continuation

RIPE: Rifampin, INH, Pyrazinamide, ethambutol

37
Q

Treatment for drug resistant TB

A

Sensitivity testing

38
Q

MDR-TB therapy includes

A

Fluoroquinolones, injectable antibiotics

39
Q

Directly Observed Therapy

A

Providing drugs to patients and watching them swallow meds.
Ensures adherence.
Fixed dose combo drugs increases adherence (i.e INH + rifampin or INH + rifampin + PZA)

40
Q

Latent TB Infection Drug Therapy

A

Drug therapy helps prevent active TB
Usually only one drug
9 months daily INH

41
Q

BCG Vaccine

A

Live strain of mycobacterium bovis
Given in high prevalence areas
If meet criteria
E.g. health care workers who are constantly exposed too

42
Q

Assessment of TB

A

Previous hx TB, chronic illnesses, immunosuppressants

Social and occupational hx → determine risk factors

43
Q

Health Promotion for TB

A
  • Dx TB must be reported to PH
  • Improve access to health care and education
  • Minimize social determinants of TB
  • Cover nose and mouth w. tissue when sneezing or coughing
  • Hand wash
44
Q

TB Intervention Goals:

A

Promote airway clearance d/t sputum.
Promote activity and adequate nutrition.
Advocate adherence to treatment regimen.

45
Q

TB Interventions for Promoting airway clearance d/t sputum

A
  • Patient position, cough and deep breathing
  • Postural Drainage
  • Suctioning
  • Medications: expectorant
  • Hydration (liquifies secretions)
  • Humidify air (loosens secretions)
46
Q

Advocate adherence to treatment regiment to

A

Limit multiple drug resistance.

47
Q

Promote activity and adequate nutrition because

A

Malnutrition is a risk factor for TB

48
Q

If a patient is strongly suspected for TB, they

A
  1. Are placed on airborne isolation
    (Negative pressure room → sucks in the air when the door opens and releases air outside to atmosphere and never comes back into room (doesn’t recycle air) + UV rays will kill mycobacteria)
  2. Will receive medical workup
  3. Will receive appropriate drug therapy
49
Q

Ambulatory and Home Care of TB

A

Monthly sputum cultures obtained until 2 consecutive specimens are negative → not infectious
Encourage to quit smoking

50
Q

Monitoring and Managing Potential Complications of TB includes

A

Malnutrition
Side Effects of Medication Therapy: INH and rifampin
Multiple Drug Resistance
Spread of TB infection

51
Q

INH: Nursing Implications

A
  • Take on an empty stomach (1 hour before or 2 hours after meals).
  • Extra vitamin B needs to be taken while on this drug.
  • Monitor for signs of liver damage
  • Avoid Alcohol
52
Q

Adverse Effects: INH

A
  • Can cause liver damage.
  • Asymptomatic elevation of ALT, AST (liver enzymes)
  • hepatitis
53
Q

Adverse Effects: Rifampin

A
  • Hepatitis
  • Thrombocytopenia
  • Orange discoloration of bodily fluid (sputum, urine, sweat and tears.)
  • Can cause liver damage (can lead to increased bleeding time)
54
Q

Adverse Effects: PZA

A
  • Hepatitis
  • Arthralgias: Pain in joint
  • Hyperuricemia: Excessive amount of uric acid in blood
55
Q

Adverse Effects: Ethambutol

A

Ocular Toxicity (decreased red-green color discrimination)

56
Q

Ethambutol: Nursing Implications

A

Monitor visual acuity and color discrimination regularly